(Q46140705)

19 December 2017

meta-analysis

0 references

title

Genetic association of BSF2 polymorphism and susceptibility to lung cancer (English)

1 reference

19 December 2017

author name string

Hong Wang

series ordinal

1

1 reference

19 December 2017

Zhandi Liu

series ordinal

2

1 reference

19 December 2017

publication date

1 December 2014

1 reference

19 December 2017

Cell Biochemistry and Biophysics

published in

1 reference

19 December 2017

volume

70

1 reference

19 December 2017

page(s)

1887-1891

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s12013-014-0147-6

exact match

0 references

cites work

Smoking and lung cancer: the role of inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Tobacco and cancer: recent epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Lung cancer susceptibility locus at 5p15.33

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Common 5p15.33 and 6p21.33 variants influence lung cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Lack of association between the interleukin 6 gene -174G>C polymorphism and colorectal cancer: evidence from a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Human genetic variation and its contribution to complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Computational identification of gene-social environment interaction at the human IL6 locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Lack of Association between Polymorphisms in Inflammatory Genes and Lung Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-014-0147-6

10.1007/S12013-014-0147-6

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

25074527

1 reference

19 December 2017